ASSESSMENT OF NEUROLOGICAL COMPLICATIONS IN CHILDREN PRESENTING WITH PLASMODIUM VIVAX MALARIA
Article Sidebar
Main Article Content
Abstract
Objective: To assess neurological complications in children presenting with Plasmodium vivax malaria at a Tertiary Care Hospital of Peshawar.
Methodology: This descriptive cross sectional study was carried out in the Pediatric Department, Hayatabad Medical Complex, Peshawar from April 2021 to September 2021. A total of 183 patients were enrolled using convenient sampling from outpatient department with high grade fever, nausea, diarrhea, and headache, duly confirmed for Plasmodium vivax mono-infection microscopically. A pre-designed performa was used to extract information regarding demographics, laboratory investigations, and neurological complications. SPSS (version 21.0) was used to check the statistics.
Results: Out of 183 cases 71.6% were male. The mean age of the patients was 6.44±2.46 years, while mean weight was 12.76±4.56 kg. In mean duration of disease, it was recorded to be as 6.14±2.18 days. The laboratory investigations showed, low level of hemoglobin and platelets count in 38.8% and 42.2% respectively. Neurological complications were detected in 15.8% of children and were non significantly associated with gender, age group and duration of disease (stratified), and was significantly associated with the stratification of hemoglobin, hematocrit levels and platelets count.
Conclusion: A less frequent number children reported to have neurological complications when diagnosed with P. vivax. Furthermore, these complications are associated significantly with the stratification of hemoglobin, hematocrit levels and platelets count.
Article Details
Work published in JPMI is licensed under a
Creative Commons Attribution-NonCommercial 2.0 Generic License.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
References
Geneva WH. World Malaria Report 2016. World Health Organization. 2017.
WHO. World malaria report 2020: 20 years of global progress and challenges. World malaria report 2020: 20 years of global progress and challenges.2020:299.
WHO. World malaria report 2013. World Health Organization; 2014.
Howes RE, Battle KE, Mendis KN, Smith DL, Cibulskis RE, Baird JK, Hay SI. Global epidemiology of Plasmodium vivax. Am J Trop Med Hyg. 2016 :12;95(6 Suppl):15-34. DOI:10.4269/ajtmh.16-0141
Gunalan K, Lo E, Hostetler JB, Yewhalaw D, Mu J, Neafsey DE, Yan G, Miller LH. Role of Plasmodium vivax Duffy-binding protein 1 in invasion of Duffy-null Africans. Proceedings of the National Academy of Sciences. 2016; 31;113(22):6271-6. DOI: 10.1073/pnas.1606113113
Gunalan K, Niangaly A, Thera MA, Doumbo OK, Miller LH. Plasmodium vivax infections of Duffy-negative erythrocytes: historically undetected or a recent adaptation? Trends Parasitol. 2018;34(5):420-9. DOI: 10.1016/j.pt.2018.02.006
Dayanand KK, Achur RN, Gowda DC. Epidemiology, drug resistance, and pathophysiology of Plasmodium vivax malaria. J Vector Borne Dis. 2018;55(1):1-8. DOI: 10.4103/0972-9062.234620
Anstey NM, Russell B, Yeo TW, Price RN. The pathophysiology of vivax malaria. Trends Parasitol. 2009;25(5):220-7.
Rahimi BA, Thakkinstian A, White NJ, Sirivichayakul C, Dondorp AM, Chokejindachai W. Severe vivax malaria: a systematic review and meta-analysis of clinical studies since 1900. Malar J. 2014;13:1-0.
Manning L, Laman M, Law I, Bona C, Aipit S, Teine D, et al. Features and prognosis of severe malaria caused by Plasmodium falciparum, Plasmodium vivax and mixed Plasmodium species in Papua New Guinean children. PloS one. 2011;6(12):e29203.
Idro R, Jenkins NE, Newton CR. Pathogenesis, clinical features, and neurological outcome of cerebral malaria. Lancet Neurol. 2005;4(12):827-40.
Kochar DK, Sirohi P, Kochar SK, Bindal D, Kochar A, Jhajharia A, Goswami J. Post-malaria neurological syndrome-a case of bilateral facial palsy after Plasmodium vivax malaria. J Vector Borne Dis. 2007;44(3):227-29
White NJ. Determinants of relapse periodicity in Plasmodium vivax malaria. Malar J. 2011;10(1):1-36.
Tanwar GS, Khatri PC, Sengar GS, Kochar A, Kochar SK, Middha S, et al. Clinical profiles of 13 children with Plasmodium vivax cerebral malaria. Ann Trop Paediatr. 2011;31(4):351-6.
Akhlaq A, Ghanchi NK, Usmani B, Shahzad R, Rahim A, Wasay M, et al. Neurological complications in patients with Plasmodium vivax malaria from Karachi, Pakistan. J R Coll Physicians Edinb. 2018;48(3):198-201.
White NJ. Determinants of relapse periodicity in Plasmodium vivax malaria. Malar J. 2011;10(1):1-36.
Koibuchi T, Nakamura T, Iwamoto A, Miura T, Endo T, Nakamura H, et al. Acute disseminated encephalomyelitis following Plasmodium vivax malaria. J Infect Chemother. 2003;9(3):254-6.
Ghosh S. Curious association between Plasmodium vivax malaria and nontraumatic acute subdural hematoma. Indian J Crit Care Med. 2014;18(5):335-7. DOI: 10.4103/0972
Venugopal V, Haider M. First case report of acute hemorrhagic leukoencephalitis following Plasmodium vivax infection. Indian J Med Microbiol. 2013;31(1): 79-81. DOI:10.4103/0255-0857.108736.
Sim JE, Choi YC, Kim WJ. Facial diplegia in Plasmodium vivax malaria. J Clin Neurol. 2010;6(2):102-3.
Sohaib A, Nadia S, Nowneet KB, Minakshi D, Garima M, Manish M, et al. A Hospital-Based Retrospective Comparative Study of Complications, Outcomes, Clinical and Laboratory Parametersof Malaria with and without Neurological Involvement. Mediterr J Hematol Infect. Dis. 2017; 9(1):1-9. DOI: 10.4084/MJHID.2017.006
Zubairi AB, Nizami S, Raza A, Mehraj V, Rasheed AF, Ghanchi NK, et al. Severe Plasmodium vivax malaria in Pakistan. Emerg Infect Dis. 2013;19(11):1851-4. DOI: 10.3201/eid1911.130495